Skip to content

Category: Top Stories

Traders now see little chance of an interest rate cut this year following Fed decision

Business Men Break Sit Read Newspaper

All of the positive economic talk out of this week’s Federal Reserve meeting had a negative impact on investors

Jim Cramer’s top 10 things to watch in the stock market Thursday

Business Men Break Sit Read Newspaper

Stocks tumbled this morning as the U.S.-Iran war continues to escalate and oil prices spike.

Here are Thursday’s biggest analyst calls: Nvidia, Apple, Tesla, Micron, Carnival, Palantir, Five Below, Intuit & more

Business Men Break Sit Read Newspaper

Here are Thursday’s biggest calls on Wall Street.

Hegseth says potential $200 billion Iran war spending request could shift: ‘Takes money to kill bad guys’

Business Men Break Sit Read Newspaper

President Donald Trump’s National Economic Council director Kevin Hassett said Sunday that the war has already cost $12 billion.

Trump’s DHS pick Markwayne Mullin to get Senate committee vote

Business Men Break Sit Read Newspaper

President Donald Trump tapped Sen. Markwayne Mullin, R-Okla., earlier this month to replace Kristi Noem.

This cruise stock is down sharply since U.S.-Iran war began. Morgan Stanley says buy the dip

Business Men Break Sit Read Newspaper

Carnival Corporation’s more than 23% fall since the start of the U.S.-Iran war is similar to the impact other military conflicts have had on the stock.

Uber to invest up to $1.25 billion in EV maker Rivian in deal to launch 50,000 robotaxis

Business Men Break Sit Read Newspaper

Uber plans to invest up to $1.25 billion in Rivian as part of a deal to deploy up to 50,000 robotaxis in several countries through 2031.

Stocks making the biggest moves premarket: Micron, Alibaba, Five Blow, Newmont and more

Business Men Break Sit Read Newspaper

These are the stocks posting the largest moves in the premarket.

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

Business Men Break Sit Read Newspaper

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill, orforglipron. 

Micron falls more than 5% despite blockbuster earnings. Here’s what market watchers are saying

Business Men Break Sit Read Newspaper

Wednesday’s blockbuster earnings were not enough to stop shares in Micron Technology from falling 5.5% in pre-market trading. 

← Previous
Next →

Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!

JOIN OUR COMMUNITY

Join our growing community of educated investors working together to build wealth with a diversified outlook at investment opportunities

Copyright © 2023. All Rights Reserved.

  • Privacy & Policy
  • Disclaimer